ACADIA Pharmaceuticals Inc (ACAD) Stock Price

24.84 ▲ +0.01 (+0.04%)
Open: 25.10 Vol: 982.56K Day's range: 24.57 - 25.10 Jul 24, 16:00 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
ACAD Technical Analysis
5 mins 30 mins Hourly Daily Weekly
BUY BUY BUY SELL BUY
  5 mins 30 mins Hourly Daily Weekly
MA5 24.82▲ 24.70▲ 24.72▲ 25.03▼ 25.59▼
MA10 24.79▲ 24.71▲ 24.76▲ 25.33▼ 23.50▲
MA20 24.73▲ 24.78▲ 24.86▼ 25.54▼ 22.54▲
MA50 24.71▲ 24.96▼ 25.24▼ 23.17▲ 23.63▲
MA100 24.75▲ 25.29▼ 25.55▼ 22.52▲ 20.92▲
MA200 24.83▲ 25.55▼ 24.50▲ 23.50▲ 20.90▲
  5 mins 30 mins Hourly Daily Weekly
MACD 0.014▲ 0.017▲ 0.010▲ -0.252▼ 0.492▲
RSI 64.523▲ 51.748▲ 45.477▼ 52.384▲ 56.827▲
STOCH 90.279▲ 50.830     40.476     24.040     70.426    
WILL %R -3.125▲ -27.632     -21.014▲ -73.310     -35.235    
CCI 134.826▲ 89.142     15.042     -133.160▼ 79.969    
Latest Filters Detected On ACAD
MA $ACAD Price Crossed Below MA(26) Set Alert
ACADIA Pharmaceuticals Inc News
ACADIA (ACAD) Upgraded to Buy After Recent Pullback
Saturday, May 02, 2026 06:51 AM
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) ranks among the most profitable biotech stocks to buy now. On March 25, BofA Securities raised ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) to Buy from Neutral, ...
Exclusive BAC Article: Acadia Pharmaceuticals; Remilfanserin ADP Data August - October 2026, Over $1 Billion Sales Full-Year 2025, And Catalysts
Thursday, February 26, 2026 11:57 AM
I believe that a good speculative biotech to go over for the "Exclusive BAC Subscribers Article" would be Acadia Pharmaceuticals (ACAD). The reason why I want to go over this company next is because ...
Acadia Pharmaceuticals Announces Phase 3 COMPASS PWS Trial of Intranasal Carbetocin (ACP-101) for Hyperphagia in Prader-Willi Syndrome Did Not Meet Primary Endpoint
Wednesday, September 24, 2025 04:00 AM
SAN DIEGO--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced top-line results from the Phase 3 COMPASS PWS trial evaluating the efficacy and safety of intranasal carbetocin ...
ACAD historical stock data
date open high low close volume
24/07/26 25.10 25.10 24.57 24.84 982,562
23/07/26 24.232 25.00 24.232 24.83 1,272,012
22/07/26 25.59 25.62 24.91 24.96 1,136,136
21/07/26 25.20 25.57 25.07 25.43 1,284,489
20/07/26 26.07 26.16 25.03 25.09 1,486,528
17/07/26 25.37 25.835 25.20 25.60 1,139,988
16/07/26 26.00 26.23 25.47 25.63 2,114,874
15/07/26 25.38 26.08 25.1804 25.92 1,273,559
14/07/26 25.58 25.64 24.955 25.49 1,221,006
13/07/26 26.04 26.04 25.30 25.50 1,539,291
Quote Details
52wk Low:19.69
52wk High:28.35
Vol:982.56K
Avg Vol(3m):30.1M
1Y Chng:+0.08%
1M Chng:+16.13%
Add to Watch List
More Information
Index US Composite
Market Cap. 4.25B